Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Na,K-ATPase alpha subunit | 0.0259 | 0.1832 | 1 |
Schistosoma mansoni | ATPase | 0.0089 | 0.0287 | 0.0626 |
Schistosoma mansoni | sodium / potassium ATPase beta chain | 0.0421 | 0.3298 | 0.8034 |
Entamoeba histolytica | Plasma membrane calcium-transporting ATPase, putative | 0.0089 | 0.0287 | 0.7755 |
Loa Loa (eye worm) | hypothetical protein | 0.0201 | 0.1305 | 0.3112 |
Trypanosoma brucei | vacuolar-type Ca2+-ATPase 2 | 0.0089 | 0.0287 | 0.7455 |
Echinococcus granulosus | sodium:potassium dependent atpase beta subunit | 0.0508 | 0.4097 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0508 | 0.4097 | 1 |
Echinococcus granulosus | sarco:endoplasmic reticulum calcium ATPase | 0.0089 | 0.0287 | 0.0626 |
Schistosoma mansoni | plasma membrane calcium-transporting atpase | 0.0099 | 0.037 | 0.083 |
Echinococcus multilocularis | Ca2+ transporting ATPase plasma membrane | 0.0099 | 0.037 | 0.083 |
Mycobacterium tuberculosis | Probable isocitrate lyase AceAa [first part] (isocitrase) (isocitratase) (Icl) | 0.1157 | 1 | 0.5 |
Echinococcus granulosus | plasma membrane calcium transporting ATPase 2 | 0.0099 | 0.037 | 0.083 |
Plasmodium falciparum | non-SERCA-type Ca2+ -transporting P-ATPase | 0.0099 | 0.037 | 0.5 |
Schistosoma mansoni | calcium-transporting atpase sarcoplasmic/endoplasmic reticulum type (calcium pump) | 0.0099 | 0.037 | 0.083 |
Trypanosoma brucei | calcium motive p-type ATPase, putative | 0.0099 | 0.037 | 1 |
Echinococcus multilocularis | calcium transporting atpase | 0.0099 | 0.037 | 0.083 |
Schistosoma mansoni | transmemberane protein | 0.0508 | 0.4097 | 1 |
Schistosoma mansoni | sodium/potassium-dependent atpase beta subunit | 0.0508 | 0.4097 | 1 |
Schistosoma mansoni | Na+/K+ transporting ATPase subunit alpha | 0.0259 | 0.1832 | 0.4428 |
Echinococcus granulosus | calcium transporting ATPase type 2C member | 0.0099 | 0.037 | 0.083 |
Echinococcus granulosus | nervana 2 | 0.0421 | 0.3298 | 0.8034 |
Mycobacterium leprae | Isocitrate lyase | 0.0542 | 0.4408 | 0.348 |
Mycobacterium tuberculosis | Probable isocitrate lyase AceAb [second part] (isocitrase) (isocitratase) (Icl) | 0.1157 | 1 | 0.5 |
Trypanosoma brucei | vacuolar-type Ca2+-ATPase 1 | 0.0089 | 0.0287 | 0.7455 |
Trichomonas vaginalis | plasma membrane calcium-transporting ATPase, putative | 0.0099 | 0.037 | 1 |
Echinococcus multilocularis | plasma membrane calcium transporting ATPase | 0.0099 | 0.037 | 0.083 |
Echinococcus granulosus | Ca2 transporting ATPase plasma membrane | 0.0099 | 0.037 | 0.083 |
Echinococcus granulosus | plasma membrane calcium transporting ATPase | 0.0099 | 0.037 | 0.083 |
Schistosoma mansoni | na+/k+ atpase alpha subunit | 0.0259 | 0.1832 | 0.4428 |
Mycobacterium ulcerans | isocitrate lyase AceAb | 0.1157 | 1 | 1 |
Trypanosoma cruzi | plasma membrane Ca2+ ATPase | 0.0089 | 0.0287 | 0.7455 |
Brugia malayi | Sodium/potassium-transporting ATPase alpha chain, putative | 0.0224 | 0.1506 | 0.822 |
Echinococcus granulosus | sodium:potassium dependent atpase beta subunit | 0.0508 | 0.4097 | 1 |
Echinococcus granulosus | Na:K ATPase alpha subunit | 0.0259 | 0.1832 | 0.4428 |
Echinococcus multilocularis | sodium:potassium dependent atpase beta subunit | 0.0421 | 0.3298 | 0.8034 |
Toxoplasma gondii | plasma membrane-type Ca(2+)-ATPase A1 PMCAA1 | 0.0099 | 0.037 | 1 |
Trypanosoma brucei | vacuolar-type Ca2+-ATPase, putative | 0.0089 | 0.0287 | 0.7455 |
Echinococcus multilocularis | Tetracycline resistance leader peptide, TetL | 0.0099 | 0.037 | 0.083 |
Trypanosoma brucei | calcium-translocating P-type ATPase | 0.0099 | 0.037 | 1 |
Plasmodium vivax | P-type ATPase4, putative | 0.0099 | 0.037 | 0.5 |
Echinococcus multilocularis | sodium:potassium dependent atpase beta subunit | 0.0508 | 0.4097 | 1 |
Echinococcus granulosus | sodium:potassium transporting ATPase subunit | 0.0508 | 0.4097 | 1 |
Plasmodium falciparum | calcium-transporting ATPase | 0.0099 | 0.037 | 0.5 |
Echinococcus multilocularis | sodium:potassium dependent atpase beta subunit | 0.0508 | 0.4097 | 1 |
Leishmania major | P-type ATPase, putative | 0.0099 | 0.037 | 1 |
Schistosoma mansoni | sodium/potassium-dependent atpase beta subunit | 0.0421 | 0.3298 | 0.8034 |
Echinococcus granulosus | nervana 2 | 0.0508 | 0.4097 | 1 |
Echinococcus granulosus | sodium:potassium dependent atpase beta subunit | 0.0421 | 0.3298 | 0.8034 |
Loa Loa (eye worm) | sodium/potassium-transporting ATPase subunit alpha | 0.0224 | 0.1506 | 0.3608 |
Leishmania major | calcium motive p-type ATPase, putative | 0.0099 | 0.037 | 1 |
Schistosoma mansoni | calcium-transporting atpase 2 (atpase 2) | 0.0099 | 0.037 | 0.083 |
Schistosoma mansoni | calcium-transporting atpase sarcoplasmic/endoplasmic reticulum type (calcium pump) | 0.0099 | 0.037 | 0.083 |
Loa Loa (eye worm) | hypothetical protein | 0.0259 | 0.1832 | 0.4412 |
Trichomonas vaginalis | plasma membrane calcium-transporting ATPase, putative | 0.0099 | 0.037 | 1 |
Echinococcus granulosus | nervana 2 | 0.0421 | 0.3298 | 0.8034 |
Loa Loa (eye worm) | hypothetical protein | 0.0508 | 0.4097 | 1 |
Brugia malayi | Probable calcium-transporting ATPase KIAA0703 | 0.0063 | 0.0044 | 0.0238 |
Plasmodium vivax | calcium-transporting ATPase, putative | 0.0099 | 0.037 | 0.5 |
Trypanosoma cruzi | calcium motive p-type ATPase, putative | 0.0099 | 0.037 | 1 |
Mycobacterium tuberculosis | Isocitrate lyase Icl (isocitrase) (isocitratase) | 0.1157 | 1 | 0.5 |
Giardia lamblia | Potassium-transporting ATPase alpha chain 1 | 0.0259 | 0.1832 | 1 |
Toxoplasma gondii | P-type ATPase4, putative | 0.0099 | 0.037 | 1 |
Echinococcus multilocularis | nervana 2 | 0.0508 | 0.4097 | 1 |
Echinococcus multilocularis | nervana 2 | 0.0421 | 0.3298 | 0.8034 |
Echinococcus granulosus | calcium transporting atpase | 0.0099 | 0.037 | 0.083 |
Loa Loa (eye worm) | hypothetical protein | 0.0089 | 0.0287 | 0.06 |
Mycobacterium ulcerans | isocitrate lyase Icl | 0.1157 | 1 | 1 |
Onchocerca volvulus | 0.0508 | 0.4097 | 1 | |
Entamoeba histolytica | Plasma membrane calcium-transporting ATPase, putative | 0.0089 | 0.0287 | 0.7755 |
Leishmania major | calcium-transporting ATPase, putative | 0.0099 | 0.037 | 1 |
Mycobacterium ulcerans | metal cation transporter p-type ATPase a | 0.025 | 0.1749 | 0.1432 |
Trypanosoma cruzi | plasma membrane Ca2+ ATPase | 0.0089 | 0.0287 | 0.7455 |
Echinococcus multilocularis | Na+:K+ ATPase alpha subunit | 0.0259 | 0.1832 | 0.4428 |
Echinococcus granulosus | nervana 2 | 0.0508 | 0.4097 | 1 |
Brugia malayi | Membrane calcium atpase protein 3 | 0.0099 | 0.037 | 0.2018 |
Echinococcus multilocularis | nervana 2 | 0.0421 | 0.3298 | 0.8034 |
Onchocerca volvulus | 0.0421 | 0.3298 | 0.6596 | |
Loa Loa (eye worm) | hypothetical protein | 0.0161 | 0.0936 | 0.22 |
Echinococcus multilocularis | sarco:endoplasmic reticulum calcium ATPase | 0.0089 | 0.0287 | 0.0626 |
Echinococcus multilocularis | calcium transporting ATPase type 2C member | 0.0099 | 0.037 | 0.083 |
Echinococcus multilocularis | sodium:potassium transporting ATPase subunit | 0.0508 | 0.4097 | 1 |
Echinococcus multilocularis | nervana 2 | 0.0508 | 0.4097 | 1 |
Schistosoma mansoni | ATPase | 0.0089 | 0.0287 | 0.0626 |
Trypanosoma cruzi | Calcium ATPase SERCA-like | 0.0089 | 0.0287 | 0.7455 |
Trypanosoma cruzi | calcium motive p-type ATPase, putative | 0.0099 | 0.037 | 1 |
Entamoeba histolytica | Plasma membrane calcium-transporting ATPase, putative | 0.0089 | 0.0287 | 0.7755 |
Loa Loa (eye worm) | hypothetical protein | 0.0174 | 0.1053 | 0.2491 |
Entamoeba histolytica | calcium-transporting P-type ATPase, putative | 0.0099 | 0.037 | 1 |
Schistosoma mansoni | sodium/potassium-dependent atpase beta subunit | 0.0508 | 0.4097 | 1 |
Loa Loa (eye worm) | Na,K-ATPase alpha subunit | 0.0259 | 0.1832 | 0.4412 |
Schistosoma mansoni | plasma membrane calcium-transporting atpase | 0.0099 | 0.037 | 0.083 |
Toxoplasma gondii | sarco/endoplasmic reticulum Ca2+-ATPase | 0.0099 | 0.037 | 1 |
Brugia malayi | Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type | 0.0099 | 0.037 | 0.2018 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.